Table: Kidswell Bio -Q1 group results
Aug 13 (Reuters)-
Kidswell Bio Corporation
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2025 Jun 30, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1.72 482 mln
(+256.3 pct)
Operating 184 mln loss 158 mln
Recurring 175 mln loss 176 mln
Net 157 mln loss 176 mln
EPS 3.31 yen loss 4.49 yen
EPS Diluted 3.26 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Kidswell Bio Corporation.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4584.T